1-5 of 5
Dustin Whitney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Universal Cloaking of Allogeneic T Cell Therapies Against Natural Killer Cells Via CD300a Agonism

G. Grant Welstead, Shuqi Zhang, Justin Fang, Faith Thomas, Andriana Lebid, Mike Miller, Daniel Perry, Dustin Whitney, Jill Carton, Jonathan Kurtz, Chad Cowan
Journal: Blood
Blood (2024) 144 (Supplement 1): 4821.
https://doi.org/10.1182/blood-2024-211844
Published: 2024
Journal Articles

Successful Generation of iPSC-Derived CD4 + and CD8 + CAR T Cells with Αβ-like T Cell Function, Including Antigen-Dependent Expansion and IL-2 Production

Dar Heinze, Killian Sottoriva, Kristen Dettloff, Melissa Chin, Justin Gallagher, Alexa Galuppo, Kristen Fread, Justin Fang, Ryan Hasselkus, Sarah Thomas, Eric Ma, Ynes Helou, David Bauer, Jonathan Kurtz, Dustin Whitney, Chad Cowan, G. Grant Welstead
Journal: Blood
Blood (2024) 144 (Supplement 1): 4819.
https://doi.org/10.1182/blood-2024-210428
Published: 2024
Journal Articles

Long Term Outcomes of 63 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed up to 7 Years Post-Treatment with betibeglogene autotemcel (beti-cel) Gene Therapy and Exploratory Analysis of Predictors of Successful Treatment Outcomes in Phase 3 Trials

Mark C. Walters, Janet L. Kwiatkowski, John B. Porter, Jennifer Schneiderman, Suradej Hongeng, Andreas E. Kulozik, Marina Cavazzana, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, John E.J. Rasko, Evangelia Yannaki, Shamshad Ali, Ilya Shestopalov, Maeva Fincker, Richard A. Colvin, Dustin Whitney, Franco Locatelli, Alexis A. Thompson
Journal: Blood
Blood (2022) 140 (Supplement 1): 5355–5357.
https://doi.org/10.1182/blood-2022-162400
Published: 2022
Journal Articles

Polyclonality Strongly Correlates with Biological Outcomes and Is Significantly Increased Following Improvements to the Phase 1/2 HGB-206 Protocol and Manufacturing of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy (GT)

John F. Tisdale, Alexis A. Thompson, Markus Y. Mapara, Janet L. Kwiatkowski, Lakshmanan Krishnamurti, Banu Aygun, Kimberly A. Kasow, Stacey Rifkin-Zenenberg, Manfred Schmidt, Francis J. Pierciey, Jr., Dustin Whitney, Cynthia Rogers, Mauris Nnamani, Marianna Foos, Alex Miller, Xinyan Zhang, Jessie Lynch, Mark C. Walters, Julie Kanter, Melissa Bonner
Journal: Blood
Blood (2021) 138 (Supplement 1): 561.
https://doi.org/10.1182/blood-2021-147760
Published: 2021
Journal Articles

Response of Patients with Transfusion-Dependent β-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers

Mark C. Walters, MD, David H.K. Chui, MD FRCPC, John J Farrell, PhD, Ashutosh Lal, MD, Franco Locatelli, MD PhD, Janet L. Kwiatkowski, MD MSCE, John B. Porter, MA, MD, FRCP, FRCPath, Martin G. Sauer, MD, Isabelle Thuret, MD, Suradej Hongeng, MD, Andreas E. Kulozik, MD PhD, Adrian J. Thrasher, MBBS, PhD FMedSci, Evangelia Yannaki, MD, Julia Yang, Dustin Whitney, PhD, Alexandria Petrusich, Richard A. Colvin, MD PhD, Alexis A. Thompson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-137642
Published: 2020